Donatuss DC Syrup and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Donatuss DC Syrup and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydrocodeine / guaifenesin / phenylephrine
Brand name:
Synonyms: n.a.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Donatuss DC Syrup-Moxifloxacin
- Donatuss DC Syrup-Moxifloxacin (Systemic)
- Donatuss DC Syrup-Moxifloxacin Hydrochloride
- Donatuss DC Syrup-Moxifloxacin Injection
- Donatuss DC Syrup-Moxifloxacin Intravenous
- Donatuss DC Syrup-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Donatussin
- Moxetumomab pasudotox-tdfk Intravenous-Donatussin Drops
- Moxetumomab pasudotox-tdfk Intravenous-Donepezil
- Moxetumomab pasudotox-tdfk Intravenous-Donepezil 23 mg Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Donepezil and memantine
- Moxetumomab pasudotox-tdfk Intravenous-Donepezil ER Tablets